VP, Intellectual Property Business Strategy
An assessment of the various options available to your organisation with regards to monetisation,
How can you further monetize your IP assets through licensing, cross-licensing etc?
Focusing on licensing patents to start-ups, right of reference to clinical data, software and tools, and technology licenses outside of your core markets
Taking a broad view of un-used and non-core IP including trademarks and discontinued products opens up additional opportunities to monetize a life-science IP portfolio.